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Michael Detmar 1,*ABSTRACT
Objective: Elevated serum levels of the lymphangiogenic factors VEGF-C and -D have been observed in obese individuals but their relevance for
the metabolic syndrome has remained unknown.
Methods: K14eVEGFR-3eIg (sR3) mice that constitutively express soluble-VEGFR-3eIg in the skin, scavenging VEGF-C and -D, and wildtype
(WT) mice were fed either chow or high-fat diet for 20 weeks. To assess the effect of VEGFR-3 blockage on adipose tissue growth and insulin
sensitivity, we evaluated weight gain, adipocyte size and hepatic lipid accumulation. These results were complemented with insulin tolerance
tests, FACS analysis of adipose tissue macrophages, in vitro 3T3-L1 differentiation assays and in vivo blocking antibody treatment experiments.
Results: We show here that sR3 mice are protected from obesity-induced insulin resistance and hepatic lipid accumulation. This protection is
associated with enhanced subcutaneous adipose tissue hyperplasia and an increased number of alternatively-activated (M2) macrophages in
adipose tissue. We also show that VEGF-C and -D are chemotactic for murine macrophages and that this effect is mediated by VEGFR-3, which is
upregulated on M1 polarized macrophages. Systemic antibody blockage of VEGFR-3 in db/db mice reduces adipose tissue macrophage inﬁltration
and hepatic lipid accumulation, and improves insulin sensitivity.
Conclusions: These results reveal an unanticipated role of the lymphangiogenic factors VEGF-C and -D in the mediation of metabolic syndrome-
associated adipose tissue inﬂammation. Blockage of these lymphangiogenic factors might constitute a new therapeutic strategy for the prevention
of obesity-associated insulin resistance.
 2014 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Obesity is a growing public health problem and its prevalence has
reached epidemic proportions in recent decades [1]. Obesity and
associated metabolic syndrome are accompanied by heightened levels
of proinﬂammatory mediators, not only systemically but also locally in
metabolically critical tissues such as adipose tissue, liver and skeletal
muscle [2]. A plethora of studies has shown that an increase in
proinﬂammatory mediators such as tumor necrosis factor (TNF)-a,
interleukin (IL)-6 and macrophage chemotactic protein (MCP)-1 results
in adipose tissue insulin resistance [3e6], adipocyte lipolysis [7] and
hepatic steatosis [6], eventually leading to systemic insulin resistance
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propagating obesity-induced adipose tissue inﬂammation [9e11].
Macrophage polarization is generally classiﬁed as M1 (proin-
ﬂammatory) or M2 (anti-inﬂammatory) phenotype, mirroring the Th1e
Th2 lymphocyte subsets [12e14]. In obesity, increased numbers of
macrophages have been found in adipose tissue, with a shift towards
the M1-polarized state that elicits effector functions by the production
of a surplus of proinﬂammatory cytokines and promotes adipocyte
insulin resistance [15]. While the increase in macrophage numbers in
obesity has been largely attributed to an enhanced expression of MCP-
1 by the hypertrophied adipocytes [16] or lipid sensing of macrophages
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Original articleElevated serum levels of VEGF-A, -C [18] and -D [19] have been re-
ported in overweight and in obese subjects, and serum VEGF-C levels
appear to be more closely correlated with metabolic and lipid pa-
rameters than serum VEGF-A levels in obese patients [20]. VEGF-C and
-D are potent activators of lymphatic vessel growth (lymphangio-
genesis) via VEGFR-3 signaling [21,22], and impaired lymphatic vessel
function is associated with increased adipocyte accumulation [23],
whereas lymphatic vessel function is reduced in obese individuals [24]
as well as in obese mice [25]. Previously, VEGF-A has been implicated
in the pathogenesis of metabolic syndrome since overexpression of
VEGF-A in adipose tissue promotes accumulation of an M2-polarized
macrophage population and associates with improved insulin sensi-
tivity [26,27]. While no major adipose tissue phenotype was found in
VEGF-D deﬁcient mice [28], the biological role of the VEGF-C/VEGF-D/
VEGFR-3 axis in obesity has remained largely unknown.
To investigate the potential role of VEGF-C and -D in diet-induced
obesity, we subjected K14esVEGFR-3eIg transgenic mice (sR3
mice), which express the extracellular domain of human VEGFR-3,
fused to the Fc domain of the human Ig gamma chain, under the
control of the keratin 14 promoter [29], to high-fat diet (HFD). The sR3
protein scavenges endogenous VEGF-C and -D, resulting in a lack of
dermal lymphatic vessels and in lymphedema [29]. We also treated db/
db mice with a VEGFR-3 blocking antibody during the development of
insulin resistance. Our results identify a key role for the VEGF-C/VEGF-
DeVEGFR-3 pathway in the development of adipose tissue insulin
resistance by contributing to the recruitment of inﬂammatory macro-
phages. Therefore, the blockade of VEGF-C and -D might represent a
new therapeutic approach to alleviate diet-induced insulin resistance.Figure 1: Comparable weight gain, fat distribution and intestinal lipid uptake in sR3 mice.
in the tail. Whole-mount imaging of intestinal villi of WT and sR3 mice revealed no diffe
expression does not inﬂuence weight gain or adipose tissue distribution during chow diet
weight gain P ¼ 0.30). (C) CT scan analyses and further calculation showed comparab
ﬂuorescence in the serum 1 h after oral ingestion revealed similar lipid uptake in WT an
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2.1. Comparable weight gain and lipid uptake in sR3 and WT mice
In sR3 mice, the sR3 protein secreted by epidermal keratinocytes
captures the lymphangiogenic growth factors VEGF-C and -D, thereby
inhibiting VEGFR-3 signaling [29]. We found that sR3 mice had a lack
of podoplanin-positive lymphatic vessels in the tail and back skin,
conﬁrming the transgene activity (Figure 1A and data not shown). The
sR3 protein was also detectable by ELISA in the subcutaneous white
adipose tissue (SWAT), which is in close proximity to the skin where
the transgene is produced (Figure S1). In contrast, it was not detect-
able in the epididymal white adipose tissue (EWAT) or in the liver of sR3
transgenic mice (Figure S1). An X-gal staining performed on mice
expressing the LacZ enzyme under control of the VEGFR-3 promoter
(Flt4CreErt2; Rosa26LacZ double knock-in mice [30]) revealed that
there were VEGFR-3 positive lymphatic vessels in tissues such as the
mesentery and the intestine (Figure S2A and B), but there were no
VEGFR-3 expressing cells in the adipose tissue except for collecting
lymphatic vessels and lymph nodes (Figure S2C).
To investigate if the neutralization of VEGF-C and -D might affect diet-
induced obesity, four-week-old male sR3 mice and their wildtype (WT)
littermates on the FVB background were fed with either chow or high-
fat diet (HFD) for 20 weeks. WT and sR3 mice gained a similar amount
of weight under HFD (WT: 26.8  2.5 g, n ¼ 8; sR3: 26.4  1.9 g,
n ¼ 13; P ¼ 0.708). Similarly, the weight gain under chow diet was
comparable for both genotypes (WT: 17.4  3.8 g, n ¼ 9; sR3:
18.4  4.3 g, n ¼ 13; P ¼ 0.477; Figure 1B). Computed-tomography
scan analyses and further calculation showed comparable weights of(A) Compared to WT mice, sR3 mice lack podoplanin positive dermal lymphatic vessels
rences in lacteal or blood vessel structure. Scale bars ¼ 100 mm. (B) sVEGFR-3eIg
or HFD (n ¼ 8e13, data analyzed with repeated measures ANOVA; genotype effect on
le adipose tissue weights in mice on HFD (n ¼ 5e6). (D) Determination of BODIPY
d sR3 mice (n ¼ 3e4, two-tailed Student’s t-test). All data are mean  SD.
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SWAT (WT: 8.2 1.3 g, n¼ 5; sR3: 8.3 0.6 g, n¼ 6; P¼ 0.92) and
of EWAT (WT: 5.2  0.3 g; sR3: 4.9  0.1 g; P ¼ 0.42) between WT
and sR3 mice (Figure 1C). Since the sR3 protein is detectable in the
systemic circulation of sR3 mice [29,31], we next investigated whether
intestinal lipid uptake by lacteal lymphatic vessels might be impaired.
Whole-mount stainings of intestines revealed normal lacteal vessels in
sR3 mice (Figure 1A). Moreover, similar amounts of the lipophilic dye
BODIPY were found in sera of sR3 and WT mice at 1 h after intra-
gastric administration (WT: 14,000  1347 arbitrary units (AU),
n ¼ 4; sR3: 12,920  1442 AU, n ¼ 3; P ¼ 0.61; Figure 1D), indi-
cating that the circulating sR3 did not interfere with the lipid absorption
of intestinal lacteal vessels.
2.2. sR3 mice on HFD have smaller SWAT adipocytes
Since insulin resistance is usually associated with hypertrophic
obesity, we investigated potential systemic effects of the sR3 protein
and quantiﬁed the size of adipocytes under HFD and chow diet. We
found that the SWAT, but not the EWAT adipocytes were markedly
smaller in sR3 mice than in WT mice under chow diet (Figure 2A and
B). After 20 weeks of HFD, the adipocyte size was signiﬁcantly
increased in both WT and sR3 mice but the SWAT adipocytes were still
smaller in sR3 mice than in WT mice (Figure 2A). The size distribution
of SWAT adipocytes was then plotted in a cumulative frequency graph
(Figure 2C). There was a signiﬁcant leftward shift in the cumulative
frequency of adipocyte sizes in sR3 mice under both diets (chow WT
n¼ 5, sR3 n¼ 10; P< 0.001; HFD WT n¼ 5, sR3 n¼ 9; P< 0.001;
two-sample KolmogoroveSmirnov test).
2.3. Enhanced insulin sensitivity of sR3 mice
Since adipocyte size is inversely correlated with insulin sensitivity [32],
we next investigated if sR3 mice have enhanced insulin sensitivity. We
found that fasting insulin levels were signiﬁcantly lower in sR3 miceFigure 2: sR3 mice have smaller subcutaneous adipocytes and are more insulin sensitive.
and HFD. (B) EWAT adipocyte size is not altered. Scale bars ¼ 100 mm. (C) Cumulative dist
mice, both on chow and on HFD (***P < 0.001; two-sample KolmogoroveSmirnov test). (
chow (n ¼ 7 each) and HFD (n ¼ 5 each) in response to insulin stimulation. Blood glucose l
(curves are compared using a two-way ANOVA, effect of genotype is shown; *P < 0.05 and
test). All data are mean  SD.
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levels were also lower in the sR3 mice than in WT mice after HFD. The
fasting glucose levels were similar in both genotypes (Table S1). The
homeostatic model assessment of insulin resistance (HOMA-IR) index
is frequently used as an indicator of insulin resistance, and metabolic
syndrome development is associated with higher HOMA-IR values [33].
We found lower HOMA-IR indices in sR3 mice than in WT mice under
both chow and HFD (Table S1). Insulin tolerance tests revealed a
signiﬁcant improvement in the response to insulin after 24 weeks of
chow or HFD in sR3 mice compared to WT mice (Figure 2D and E).
Fastingerefeeding experiments showed enhanced clearance of FFAs
from the serum of sR3 mice under chow diet, indicating better func-
tionality of the adipocytes in these mice (Table S1).
2.4. sR3 mice have reduced hepatic lipid accumulation under HFD
We next investigated ectopic lipid accumulation in the liver. The livers
of WT mice were enlarged and appeared yellow after 20 weeks of HFD,
whereas the livers of sR3 mice seemed to be protected from hepatic
steatosis and looked markedly different (Figure 3A). Oil Red O stainings
of frozen liver sections conﬁrmed reduced lipid accumulation in sR3
livers, especially under HFD, as compared to WT mice (Figure 3B).
Consistent with this ﬁnding, the liver triglyceride content was signiﬁ-
cantly reduced in sR3 mice under HFD (WT: 307.4  6.8, n ¼ 8; sR3:
223.4  7.7 mg triglyceride/g liver; n ¼ 13; P < 0.001; Figure 3C),
while the liver triglyceride content was only slightly reduced in chow
fed sR3 mice (WT: 43.1 3.5, n¼ 8; sR3: 32.3 4.3 mg triglyceride/
g liver, n¼ 13; P¼ 0.098). The sinusoidal and vascular morphology of
the livers appeared similar in WT and sR3 mice, as well as the
coverage by blood vessels, determined by measurement of the CD31
positive area (Figure 3D and E). Consistent with the lipid accumulation
phenotype, WT mice under HFD showed a signiﬁcant reduction of AKT
phosphorylation in the liver upon insulin stimulation (Figure 3F and G),(A) Compared to WT controls sR3 mice have smaller SWAT adipocytes under chow diet
ribution plot of SWAT adipocyte sizes between the groups shows a leftward shift in sR3
D, E) Insulin tolerance test (ITT) showing increased insulin sensitivity of sR3 mice under
evels of sR3 mice and WT controls before i.p. administration of insulin were set to 100%
**P < 0.01 compared to WT control at the same time point with two-tailed Student’s t-
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Figure 3: sR3 mice exhibit reduced ectopic lipid accumulation after HFD. (A) Representative appearance of steatotic livers of WT and sR3 mice after 20 weeks on HFD, note the
reduction in liver steatosis in the sR3 mice. Scale bars ¼ 1 cm. (B) Oil red O staining of liver sections conﬁrmed a reduction in lipid accumulation in the livers of sR3 mice under
both chow and HFD for 20 weeks, compared to WT mice. Scale bar ¼ 100 mm. (C) Triglyceride content measurements of the livers showed a slight reduction in the livers of sR3
mice on chow (P ¼ 0.098), and a highly signiﬁcant reduction under HFD (n ¼ 8e13, two-tailed Student’s t-test, ***P < 0.001). (D) Immunoﬂuorescence stains for CD31 (red) and
(E) subsequent image analysis showed similar coverage of liver sections with blood vessels and unaltered sinusoidal morphology. Scale bar ¼ 100 mm. (F) Representative western
blot analysis and (G) quantiﬁcation of insulin-stimulated AKT phosphorylation of liver samples, showing increased AKT phosphorylation in the sR3 mice as compared to WT controls
under HFD. Phospho-AKT levels were normalized to respective total AKT (n ¼ 4e6, two-tailed Student’s t-test, *P < 0.05). All data are mean  SD.
Original articlewhereas the livers of sR3 mice under HFD maintained high levels of
AKT phosphorylation upon insulin stimulation, indicating that they were
protected from steatosis-induced insulin resistance (Figure 3F and G).
2.5. sR3 mice on the C57BL/6 background show a similar
phenotype
To investigate whether the genetic background might affect the
phenotype, we next crossed sR3 mice into the C57BL/6 background
(sR3 B6 mice). After 10 weeks of HFD, the sR3 B6 mice had a similar
body weight compared to their WT littermates (Figure S3A) but had
lower fasting glucose (WT: 11.3  1.5; sR3 B6: 7.4  1.6 mmol/L,
n ¼ 3e4 per group; P ¼ 0.034) and fasting insulin (WT: 2.4  0.7;
sR3 B6: 1.4  0.4 ng/mL, n ¼ 3e4 per group; P ¼ 0.052) levels,
resulting in signiﬁcantly lower HOMA-IR values (WT: 32.6  12.6; sR3
B6: 13.9 2.1, n¼ 3e4 per group; P¼ 0.030; Figure S3B). The sR3
B6 mice had smaller adipocytes in both SWAT and EWAT (median
adipocyte size SWAT, WT: 3,642  511.2; sR3 B6:96 MOLECULAR METABOLISM 4 (2015) 93e105  2014 The Authors. Published by2,025  332.8 mm2, n ¼ 3e4 per group; P ¼ 0.004; EWAT WT:
7,001  1,164; sR3 B6: 5,179  557.5 mm2, n ¼ 3e4 per group;
P ¼ 0.038; Figure S3C). This was reﬂected by a signiﬁcant leftward
shift in the cumulative frequency of SWAT and EWAT adipocyte sizes in
sR3 mice (SWAT: P < 0.001; EWAT: P ¼ 0.002; two-sample Kol-
mogoroveSmirnov test; Figure S3C). The sR3 B6 mice also had
reduced hepatic lipid accumulation (WT: 214.5  36.1; sR3:
156.9  19.7 mg triglyceride/g liver; n ¼ 3e4 per group; P ¼ 0.041;
Figure S3D). SWAT macrophages of sR3 B6 mice under HFD showed
an approximately 50% reduced expression of CD11c (P ¼ 0.049) and
Tnf (P ¼ 0.027), indicating a less inﬂammatory phenotype
(Figure S3E).
2.6. Increased M2/M1 macrophage ratio in the SWAT of sR3 mice
on HFD
Recent studies have reported an altered balance of M1 and M2
macrophage subsets in obese adipose tissue [15,34], with a shiftElsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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towards M1-polarization of macrophages. Since sR3 mice showed
enhanced insulin sensitivity under both chow and HFD, we next
investigated adipose tissue macrophages and their polarization status.
We analyzed the CD11bþ/F4/80þ populations in the adipose stromal-
vascular fraction for expression levels (mean ﬂuorescence intensity,
MFI) of MHC class II antigen (M1 marker) and CD206 (M2 marker) by
FACS analyses (Figure 4A and Figure S4A). We found that sR3 mice on
HFD had a higher percentage of CD11bþ/F4/80þ macrophages in the
stromal-vascular fraction of the SWAT than WT mice (WT: 8.6 1.6%,
n ¼ 3; sR3: 24.1  6.0%, n ¼ 7; P ¼ 0.003; Figure 4B) with an
increased M2-subset in this population (Figure 4B). Importantly, sR3
mice had signiﬁcantly increased CD206/MHC II ratios in the SWAT after
20 weeks of chow (WT: 3.3  1.8, n ¼ 3; sR3: 10.7  4.2, n ¼ 3;
P¼ 0.049; Figure 4B) and HFD (WT: 1.3 0.6, n¼ 3; sR3: 6.7 4.5,
n ¼ 7; P ¼ 0.007; Figure 4B), indicating a less inﬂammatory micro-
environment. In the EWAT, this difference was more subtle
(Figure S4B). We also found that expression of CD68 (a commonFigure 4: sR3 mice have an increased ratio of M2/M1 polarized macrophages in subcutan
mice had an increase in CD11bþ/F4/80þ macrophages, as well as higher ratios of M2/M1
increased expression of CD206 in the CD11bþ/F4/80þ macrophages within the stromal-va
are mean  SD.
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HFD in sR3 mice and WT mice, whereas expression of CD11c (an M1
marker) was signiﬁcantly lower in sR3 mice than in WT mice under
HFD, further supporting a shift of macrophage polarization towards M2
in the sR3 mice (Figure S5).
2.7. CM of sR3 SWAT macrophages promote adipogenic
differentiation
It has been previously found that adipocytes of lean mice secrete Th2
cytokines to maintain an M2-promoting milieu [35], whereas diet-
induced obesity and hypertrophy of adipocytes lead to adipose tissue
inﬂammation and an M1 conversion of resident macrophages [15]. M1
type macrophages produce proinﬂammatory factors that diminish in-
sulin sensitivity and inhibit adipocyte differentiation [36e38]. We next
studied if macrophages from WT and sR3 adipose tissue have different
effects on the adipogenic differentiation of 3T3-L1 cells, a widely used
model of adipocyte differentiation [39]. CD11bþ cells, which representeous adipose tissue. (A) Representative FACS plots. (B) FACS analyses showed that sR3
polarized macrophages. This difference was due to decreased expression of MHCII and
scular fraction (n ¼ 3e7, two-tailed Student’s t-test, *P < 0.05, **P < 0.01). All data
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). 97
Original articlea mixture of M1 and M2 macrophages, were isolated from the SWAT of
chow fed sR3 mice and WT mice by magnetic-activated cell sorting
(MACS). We incubated 3T3-L1 cells with 10% conditioned media (CM)
collected from cultures of these cells (after 24 h) and assessed adi-
pogenic differentiation after 10 days. CM from WT macrophages
reduced the adipogenic differentiation of 3T3-L1 cells signiﬁcantly,
compared to the effects of CM from sR3 macrophages (Figure 5A and
B). The inhibitory effect was stronger when higher macrophage
numbers were used (Figure 5A and B).
These data suggested that macrophages from sR3 adipose tissue might
secrete less proinﬂammatory (Th1) cytokines that inhibit adipocyte dif-
ferentiation. Indeed, cytokine analyses revealed that CM from sR3 mac-
rophages lacked several proinﬂammatory cytokines (GM-CSF, IL-1a and
IL-17) that were detected in CM from WT macrophages, and that they
tended to have lower levels of IL-6 (Figure 5C). Conversely, the anti-Figure 5: Conditioned media (CM) from WT, but not sR3 SWAT macrophages inhibit ad
adipocytes stained with BODIPY 493/503 (green, lipid droplets), Syto60 (red, cytosol) and
decrease in adipogenic differentiation of the adipocytes treated with CM from WT macropha
Student’s t-test, **P < 0.01, ***P < 0.001). (C) Decreased (IL-6) or absent (IL-17, GM-C
cytokine) was only detectable in sR3 macrophage CM (n ¼ 4 each). All data are mean 
98 MOLECULAR METABOLISM 4 (2015) 93e105  2014 The Authors. Published byinﬂammatory cytokine IL-10 was detectable only in the CM of sR3 mac-
rophages (Figure 5C). These results are consistent with our ﬁndings that
macrophages in the SWAT ofWTmiceweremore of theM1-type, and they
indicate that these macrophages might contribute to insulin resistance by
reducing the differentiation of preadipocytes into mature adipocytes.
2.8. VEGF-C and -D promote chemotactic migration of murine
macrophages
Since sR3 protein neutralizes VEGF-C and -D, we next investigated if
VEGF-C and -D might exert direct effects on macrophage recruitment
and/or polarization. In WT mice, gene expression of both Vegfc and
Vegfd was signiﬁcantly upregulated in subcutaneous adipocytes after
20 weeks of HFD, as compared to chow diet (relative gene expression
normalized to levels in chow: Vegfc: chow 1.0  0.4, HFD 3.9  1.3;
n ¼ 4; P < 0.001; Vegfd: chow 1.0  0.8, HFD 3.8  1.4; n ¼ 4;ipogenic differentiation of 3T3-L1 cells. (A) Images of terminally differentiated 3T3-L1
Hoechst (blue, nuclei, scale bar ¼ 100 mm). (B) Quantiﬁcation showed a signiﬁcant
ges, compared to adipocytes treated with sR3 macrophage CM (n ¼ 4 each, two-tailed
SF, IL-1a) proinﬂammatory cytokines in CM of sR3 SWAT macrophages. IL-10 (a Th2
SD.
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P < 0.001; Figure 6A). Analyses of Vegfc and Vegfd expression,
together with CD11b, in total SWAT and EWAT of lean (C57BL/6) and
obese (db/db) mice revealed that CD11b, Vegfc and Vegfd were also
increased in EWAT in obesity (Figure S6). To investigate if VEGF-C or -D
might have direct effects on murine macrophage polarization, CD11bþ
peritoneal macrophages were isolated by MACS and incubated with
IFN-g for M1 polarization, with a combination of IL-4/IL-10/IL-13/M-
CSF for M2 polarization, or with VEGF-C or -D. While IFN-g upregu-
lated the expression of MHC class II (an M1 marker) and induced aFigure 6: VEGF-C and VEGF-D are chemotactic for macrophages. (A) The mRNA expression
(n ¼ 4 each). (B) Increased migration of peritoneal macrophages towards VEGF-C and VEG
experiments). (C) Real-time PCR demonstrated expression of VEGF-C/-D receptors and co
Blockage of neuropilin-1 or -2 did not inﬂuence macrophage migration towards VEGF-C or
and VEGF-D but migration was strongly inhibited by an anti-VEGFR-3 antibody and by sVEG
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the combination of IL-4/IL-10/IL-13/M-CSF increased the expression of
CD206, an M2 marker, and induced an elongated cellular morphology
(alternative activation) in these macrophages. None of the two cellular
polarization features were observed after incubation with VEGF-C or -D
(Data not shown). Both VEGF-C and -D, however, signiﬁcantly induced
chemotactic migration of macrophages in a transwell migration assay
(BSA control: 100  20.1%; VEGF-C: 173.5  32.8%, P ¼ 0.014;
VEGF-D: 229.8  50.9%, P ¼ 0.003, n ¼ 4 per group; Figure 6B).of Vegfc and Vegfd was increased in the adipocytes of WT mice after 20 weeks on HFD
F-D (200 ng/mL, n ¼ 3 mice per group, representative results from three independent
-receptors in adipose tissue macrophages (average Ct value for Rplp0 is 20.1). (D, E)
VEGF-D. Blockage of VEGFR-2 had no effect on macrophage migration towards VEGF-C
FR-3eIg (sR3 protein). *P < 0.05, **P < 0.01, ***P < 0.001. All data are mean  SD.
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). 99
Figure 7: Induction of polarization related markers upon M1 or M2 polarization. (A) M1
polarization associated increase in the expression of Inos and Tnf mRNA. (B) M2 po-
larization increases the expression of the mRNA levels of Mrc1, Arg1 and Ym1. Vegfr3
mRNA expression is upregulated in M1, and downregulated in M2 polarized macro-
phages. Representative data from 5 independent experiments performed with 4 bio-
logical replicates per experimental group. Dashed line represents expression level in
unstimulated macrophages. *P < 0.05, **P < 0.01. All data are mean  SD.
Original article2.9. Macrophage migration towards VEGF-C and -D is mediated by
VEGFR-3
Since both VEGF-C and -D promoted macrophage migration, we next
explored whether adipose tissue macrophages express the receptors
that bind VEGF-C and -D, namely VEGFR-2, VEGFR-3 and their co-
receptors neuropilin-1 and neuropilin-2. CD11bþ adipose tissue
macrophages were isolated from WT mice by MACS and gene
expression was studied by quantitative real-time PCR. We found that
adipose tissue macrophages expressed Nrp1 and Nrp2, as well as
Vegfr2 and Vegfr3 (Figure 6C).
To elucidate which of these receptors might mediate the migration of
macrophages towards VEGF-C and -D, we performed transwell
migration assays in the presence of receptor blocking monoclonal
antibodies against neuropilin-1, neuropilin-2, VEGFR-2 or VEGFR-3.
Blockage of neuropilin-1 or neuropilin-2 did not inhibit macrophage
migration towards VEGF-C (VEGF-Cþ IgG: 100 11.9%; anti-Nrp-1A:
92.7  22.5%; anti-Nrp-1B: 95.9  3.8%; anti-Nrp-2B:
84.8  25.4%; one-way ANOVA: NS; n ¼ 3; Figure 6D) or VEGF-D
(VEGF-D þ IgG: 100  23.2%; anti-Nrp-1A: 102.8  27.7%; anti-
Nrp-1B: 116.3  34.7%; anti-Nrp-2B: 114.4  47.8%; one-way
ANOVA: NS; n ¼ 3; Figure 6E). Similarly, blockage of VEGFR-2 had
no major effect (Figure 6D and E). In contrast, incubation with a
blocking antibody against VEGFR-3, or neutralization with sR3 protein
both strongly inhibited macrophage migration towards VEGF-C (VEGF-
C þ IgG: 100.0  6.5%; anti-VEGFR-2: 89.4  1.9%, one-way
ANOVA: NS; anti-VEGFR-3: 36.5  4.1%, P < 0.001; sVEGFR-3eIg:
32.3  6.7%, P < 0.001; n ¼ 3, Figure 6D) and VEGF-D (VEGF-
D þ IgG: 100.0  17.6%; anti-VEGFR-2: 103.8  13.8%, one-way
ANOVA: NS; anti-VEGFR-3: 45.7  20.2%, P < 0.05; sVEGFR-3eIg:
38.8  15.5%, P < 0.01; n ¼ 3, Figure 6E).
2.10. Vegfr3 mRNA is expressed by M1 but not M2 macrophages
Based on the ﬁndings that VEGF-C and -D are chemotactic for mac-
rophages, and that the sR3 mice have an increased ratio of M2/M1
macrophages in their adipose tissue, we next investigated whether
VEGFR-3 is differentially expressed by the M1 versus M2 macro-
phages. Mouse bone marrow-derived monocytes were differentiated
into macrophages by M-CSF treatment for 6 days and were then
polarized to M1 with IFN-g treatment, or to M2 with a combination of
IL-4/IL-10/IL-13/M-CSF treatment for 24 h. The M1 polarization was
conﬁrmed by the upregulation of the M1-related genes Inos and Tnf
(Figure 7A), and the M2 polarization was conﬁrmed by an increased
mRNA expression of the M2-related genes Mrc1, Arg1 and Ym1
(Figure 7B). M1-polarized macrophages showed a strong upregulation
of Vegfr3 mRNA expression, in contrast to M2-polarized macrophages
where Vegfr3 mRNA was downregulated (relative gene expression of
Vegfr3 compared to untreated controls: M1 polarized macrophages:
9.4  5.6 fold; P ¼ 0.029; M2 macrophages: 0.14  0.03 fold
P ¼ 0.029; and P ¼ 0.045 M1 compared to M2; n ¼ 4 per group;
Figure 7A).
2.11. VEGFR-3 blockade reduces SWAT macrophages in db/db
mice
We next investigated if obesity-associated inﬂammation and metabolic
syndrome in db/db mice might be reduced by inhibiting VEGFR-3
signaling during the development of insulin resistance, using sys-
temic treatment with the VEGFR-3 blocking antibody MF4-31C1 (MF4).
After two weeks of treatment, MF4 treated and control IgG treated mice
had comparable body weights (Figure 8A) and adipose tissue mass
(Figure 8B). Importantly, however, MF4 treated db/db mice were more
insulin sensitive in an insulin tolerance test (n ¼ 5 per group; two-way100 MOLECULAR METABOLISM 4 (2015) 93e105  2014 The Authors. Published byANOVA P ¼ 0.0122; Figure 8C). The MF4 treated mice also had
smaller SWAT adipocytes (median adipocyte size IgG: 9456  822.7;
MF4: 7744  535.2 mm2, n ¼ 4 per group; P ¼ 0.013; Figure 8D);
EWAT adipocyte size was comparable (median adipocyte size IgG:
11,050  874.1; MF4: 11,874  888.4 mm2; Figure 8D). MF4 treated
mice had a signiﬁcantly reduced percentage of CD11bþ/F4/80þ cells
in the SWAT (IgG: 29.5 3.7; MF4: 10.0 6.8%; n¼ 2e3 per group;
P ¼ 0.038) and a trend towards reduction in the EWAT (IgG:
30.6  6.6; MF4: 20.3  8.4%; n ¼ 2e3 per group; Figure 8E). This
reduction was in line with a subtle reduction in the mRNA levels of
CD11b, Tnf and Il6 (Figure 8F). MF4 treated mice had less hepatic lipid
accumulation than control mice, as evidenced by reduced Oil Red O
staining and lower levels of liver triglycerides (IgG: 153.8 19.5; MF4:
121.1  21.3 mg triglyceride/g liver; n ¼ 3e5 per group; P ¼ 0.074;
Figure 8G). Collectively, these ﬁndings indicate that blockage of
VEGFR-3 signaling during the development of insulin resistance has
beneﬁcial effects on the insulin sensitivity and macrophage accumu-
lation in the adipose tissue.
3. DISCUSSION
In this study, we show that blockage of the VEGFR-3 ligands VEGF-C
and -D improves systemic insulin sensitivity and protects the liver
against high-fat diet induced steatosis, associated with reducedElsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Figure 8: VEGFR-3 blocking antibody treatment impedes obesity-associated adipose tissue inﬂammation in db/db mice. (A) No difference in weight gain and (B) %SWAT and %
EWAT after 2 weeks of treatment. (C) Insulin tolerance test, (curves are compared with two-way ANOVA (effect of treatment is shown); *P < 0.05 compared to IgG control at the
same time point with two-tailed Student’s t-test). (D) Hematoxylin staining showing smaller SWAT adipocytes in MF4 treated db/db mice, whereas EWAT adipocyte size was not
changed. (E) FACS results of CD11bþ/F4/80þ cells in stromal-vascular fraction of SWAT and EWAT. (F) Relative gene expression levels of CD11b, Tnf and Il6 in SWAT and EWAT.
(G) Reduced ectopic lipid accumulation in the livers of MF4 treated mice as compared to IgG treated mice as shown by Oil Red O staining and triglyceride measurements. Scale
bars ¼ 100 mm *P < 0.05 (Two-tailed Student’s t-test compared to IgG control). All data are mean  SD.adipocyte size and adipose tissue inﬂammation, and an increased M2/
M1 macrophage ratio in adipose tissue.
Even though there were no differences in HFD-induced weight gain
and adipose tissue mass between sR3 mice and WT mice on both
the FVB and C57BL/6 genetic background, sR3 mice had signiﬁ-
cantly smaller subcutaneous adipocytes under chow and HFD, and
the decrease in subcutaneous adipocyte size was consistent with
increased insulin sensitivity as measured by insulin tolerance tests.
Enhanced adipose tissue insulin sensitivity leads to a reduction of
adipose tissue lipolysis and a reduced spillover to other tissues.
Thus, the markedly lower hepatic steatosis in sR3 mice after HFD,
together with the enhanced AKT phosphorylation in response toMOLECULAR METABOLISM 4 (2015) 93e105  2014 The Authors. Published by Elsevier GmbH. This is an open access article un
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protected against HFD-induced insulin resistance. Our ﬁnding that
the sR3 protein was detectable in the SWAT but not in the EWAT of
sR3 mice is in line with the greater effect seen in the SWAT in this
model. Since EWAT represents the metabolically more relevant
adipose tissue depot, further studies involving the targeted delivery
of the sR3 protein to all adipose depots should investigate whether
this might result in an even more pronounced effect and in a
further reduction of overall macrophage inﬁltration and
inﬂammation.
Immune cells have emerged as major players in inﬂammation-
mediated metabolic dysfunction [2,8], and a shift in macrophageder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). 101
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ﬂammatory M1 phenotype has been reported in obesity [15]. While the
related angiogenesis factor VEGF-A was found to promote the
recruitment of an M2 polarized population in combination with IL-4 in
tumors [40], the potential effects of VEGF-C and -D on adipose tissue
macrophage recruitment and polarization have remained unknown.
Our ﬁnding that Vegfc and Vegfd expression is upregulated in SWAT
adipocytes of obese mice is in line with increased VEGF-C and -D
serum levels detected in obese patients and suggests that adipose
tissue is one of the sources of VEGF-C and -D in obesity [18,19]. While
we did not ﬁnd any direct effects of VEGF-C or -D on adipogenic dif-
ferentiation of 3T3-L1 cells in vitro (data not shown), the increased
VEGF-C and -D expression by adipocytes likely promotes macrophage
recruitment into the adipose tissue, since our FACS analyses of adi-
pose tissue macrophages revealed an increased M2/M1 marker
expression ratio in the SWAT of sR3 mice where the signaling of both
VEGF-C and VEGF-D was inhibited. A likely explanation for this ﬁnding
is provided by the results of the transwell migration experiments where
both VEGF-C and -D induced chemotactic migration of murine mac-
rophages in a VEGFR-3-dependent manner. This ﬁnding is in agree-
ment with the reported VEGFR-3 expression by subsets of
macrophages [41e44], including our own previous study in human
macrophages [45] in which VEGF-C overexpressing tumors had an
increased number of peritumoral macrophages. We found that the
expression of VEGFR-3 is strongly upregulated during M1 polarization
of macrophages but not during M2 polarization, which is in line with
the LPS-induction of Vegfr3 expression in macrophages [44]. This
differential expression likely results in preferential migration of M1
polarized macrophages towards tissues with elevated levels of VEGF-C
and -D. These results indicate that VEGF-C and -D are involved in the
speciﬁc recruitment rather than the polarization of adipose tissue
macrophages. Importantly, treatment of db/db mice (a genetic mouse
model of obesity) with a VEGFR-3 blocking antibody for 2 weeks
resulted in a signiﬁcant reduction of adipose tissue inﬁltrating mac-
rophages and of Tnf and Il6 expression, together with reduced
adipocyte size and hepatic lipid accumulation, and an improvement in
insulin sensitivity. These ﬁndings, together with the reported absence
of adipose tissue changes in VEGF-D deﬁcient mice [28] indicate that
VEGF-C, rather than VEGF-D, is responsible for the metabolic changes
observed in obesity.
A possible connection between the effects of the blockade of VEGF-C
and -D on speciﬁc macrophage recruitment and reduction of adipocyte
size is provided by the ﬁnding that CM from WT, but not from sR3
adipose tissue macrophages, inhibited the adipogenic differentiation of
3T3-L1 cells. There were higher levels of proinﬂammatory cytokines in
CM from WT macrophages than in CM from sR3 macrophages. In
particular, IL-17, IL-1a and GM-CSF were detected only in WT
macrophage CM. In this context, it is of interest that IL-17 was reported
to negatively regulate adipogenesis, glucose homeostasis and obesity
[46], and that GM-CSF deﬁcient mice have improved insulin sensitivity
despite signiﬁcantly increased body weight [47]. Together, these re-
sults might explain how M2 macrophages in adipose tissue of sR3
mice facilitate adipogenic differentiation of new adipocytes, resulting in
smaller and more numerous adipocytes and in enhanced insulin
sensitivity.
Collectively, our study reveals that VEGF-C and -D play unanticipated
roles in the recruitment of M1 polarized macrophages into obese
adipose tissue and in the development of obesity-related insulin
resistance. The results of the VEGFR-3 blocking studies in db/db mice
indicate potential therapeutic strategies to reduce insulin resistance by
blockage of the VEGF-C/VEGF-DeVEGFR-3 axis, for example with an102 MOLECULAR METABOLISM 4 (2015) 93e105  2014 The Authors. Published byanti-VEGFR-3 antibody or with the sR3 protein that are already avail-
able [29,48].
4. MATERIALS AND METHODS
4.1. Mice
Male FvB-TgN(K14-VEGFR-3d1-3-Fc) (sR3) transgenic mice on FVB or
C57BL/6 backgrounds [29] and db/db mice (BKS.Cg-Dock7m þ/þ
Leprdb/J, purchased from The Jackson Lab) were maintained under
speciﬁc pathogen free (SPF) conditions. Flt4-Cre-ERT2; ROSA26-LSL-
LacZ double knock-in mice on a mixed (129/C57BL/6) background [30]
were a kind gift from S. Ortega, Spanish National Cancer Research
Centre, Madrid, Spain. Starting at the age of 4 weeks, sR3 mice and
their WT littermates were provided ad libitum with either chow diet
(11% kcal from fat, 31% kcal from protein, and 58% kcal from car-
bohydrate; Provimi-Kliba, Kaiseraugst, Switzerland) or a high-fat diet
(HFD, 60% kcal from fat, 20% kcal from protein, and 20% kcal from
carbohydrate; Research Diets Inc., NJ, USA) for 10, 20, 24 or 40
weeks. All experiments were performed in accordance with animal
protocols approved by the Kantonales Veterinäramt Zürich.
4.2. Histology
PFA-ﬁxed parafﬁn-embedded SWAT and EWAT samples were
sectioned (10 mm), deparafﬁnized, rehydrated and stained with he-
matoxylin. An average of 15e20 images at 20 magniﬁcation were
acquired per mouse. Adipocyte size was measured using the Cell-
Proﬁler software (http://www.cellproﬁler.org). For lipid staining, liver
cryosections (7 mm) were ﬁxed with PFA and stained with Oil Red O as
described [49]. For immunoﬂuorescence staining, tail, back skin and
liver cryosections (7 mm) were ﬁxed with acetone (20 C) and 80%
methanol (4 C), washed in PBS and incubated overnight with a
hamster anti-podoplanin antibody (Clone 8.1.1, Developmental Studies
Hybridoma Bank, University of Iowa, 1:200) and a rat anti-MECA-32
antibody (BD Pharmingen, 1:200) or a rat anti-CD31 antibody (BD
Pharmingen, 1:200) for visualizing lymphatic and blood vessels,
respectively. Alexa488-and Alexa594-conjugated secondary anti-
bodies and Hoechst 33342 were added (Invitrogen, Basel,
Switzerland), and images were acquired at 20 magniﬁcation. For
bright ﬁeld and ﬂuorescence imaging, an Axioskop 2 mot plus mi-
croscope (Carl Zeiss, Inc.), equipped with a Plan-APOCHROMAT 10/
0.45 NA objective, an AxioCam MRc camera and a Plan-NEOFLUAR
20/0.50 objective (Carl Zeiss, Inc.) was used. For bright-ﬁeld and
ﬂuorescence imaging of cell cultures, a Zeiss Axiovert 200 M micro-
scope equipped with a Zeiss AxioCam MRm camera with maximum
contrast, a LD-Plan NEOFLUAR 20/0.4 PhD2 Korr objective was
used. Images were acquired with Axiovision software (version 4.7.1).
4.3. Whole-mount immunoﬂuorescence stains
PFA-ﬁxed intestine samples were stained using the following primary
antibodies: rabbit anti-mouse LYVE-1 (AngioBio, 1:600), and rat anti-
mouse CD31 (BD Pharmingen, 1:250). Further details of the pro-
cedures are available in Supplemental Experimental Procedures.
4.4. Intestinal lipid uptake
Eight-week-old male mice were fasted for 3 h before administration of
250 mM BODIPY 493/503 (Invitrogen, Carlsbad, CA) in 50 mL olive oil
by oral gavage. After 1 h, mice were sacriﬁced and the blood was
collected via cardiac puncture. Serial dilutions of sera in PBS were
made, and the BODIPY ﬂuorescence in the sera was measured at
503 nm with an Inﬁnite M1000 plate reader (Tecan) and the values
were normalized to sera of mice that were gavaged with only olive oil.Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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4.5. Insulin tolerance test
For the insulin tolerance test, mice that were on chow or HFD for 10 or
22 weeks were fasted for 10 h during the light-cycle. The mice were
then injected i.p. with 0.75 U/kg (chow) or 2 U/kg (HFD or db/db) human
insulin (Sigma). Blood glucose was monitored before the injection and
after every 30 min with the Contour glucometer (Bayer HealthCare).
4.6. Insulin-stimulated AKT phosphorylation and western blot
Mice that were on chow or HFD for 24 weeks were fasted for 10 h
during the light-cycle and injected i.p. with 0.75 U/kg (chow) or 2 U/kg
(HFD) human insulin (Sigma). After 20 min, liver samples were har-
vested and snap-frozen in liquid nitrogen. The proteins were isolated
by homogenizing the liver tissues in ice-cold lysis buffer containing
20 mM Tris (pH 7.4), 150 mM NaCl, 5 mM EDTA, 25 mM NaF, 1 mM
Na3VO4, 1 mM PMSF, 1% Triton X-100 and 10% glycerol. Western
blotting was performed according to standard methods using anti-
bodies against AKT and phospho-AKTSer473 (both from Cell Signaling,
1:1000) and a corresponding horseradish peroxidase-linked secondary
antibody (GE Healthcare, 1:6000), followed by a densitometry analysis
using ImageJ software (NIH).
4.7. Blocking antibody treatment
Five-week-old male BKS db/db mice were treated with 30 mg/kg of rat
anti-mouse VEGFR-3 blocking antibody (mF4-31C1, ImClone; n¼ 5) or
rat IgG control (Sigma; n ¼ 5) every three days for 15 days (ﬁve ad-
ministrations). ITT for db/db mice was performed one day after the ﬁnal
injection as described above.
4.8. Quantiﬁcation of liver triglycerides
Liver triglycerides were extracted as described previously [50] with
minor modiﬁcations. Brieﬂy, 50 mg of liver tissue were homogenized in
1 mL hexane:isopropanol (3:2), using a Tissue-lyzer (Qiagen) with steel
beads and were centrifuged (24,000  g, 3 min). 0.5 mL Na2SO4
(470 mM) was added to the supernatant and the mixture was
centrifuged (24,000  g, 3 min). The upper organic phase was
collected and left to dry overnight. The lipids were then dissolved in
1 mL Triton-X 100:methanol:buthanol (1:1:3), and the triglyceride
levels were measured with the Triglyceride E kit (Wako) following the
manufacturer’s instructions.
4.9. Flow cytometry
Dissected SWAT and EWAT were minced in 2 mg/mL collagenase II
(Sigma), buffered with warm Ringer-lactate buffer, and incubated for
1 h at 37 C. After tissue digestion, ﬂoating mature adipocytes were
separated from the stromal-vascular fraction (SVF) via centrifugation
(200  g, 5 min at 4 C). The SVF was either used for ﬂow cytometry
or for MACS of macrophages. The macrophage population in the SVF
from dissected SWAT (n ¼ 16) and EWAT (n ¼ 20) was stained with
the following antibodies: F4/80-APC, CD11b-FITC (both from eBio-
science, 1:100) to gate double-positive cells, and CD206-PE and
MHCII-PerCP (both from Biolegend, 1:100) to assess distinct macro-
phage subsets. Each sample was stained in parallel with the corre-
sponding IgG control for CD206 and MHCII. Samples were analyzed
using a BD FACSCanto and the FACSDiva software (BD Biosciences).
Data were processed with FlowJo software Version 8.7.1 (Tree Star).
4.10. 3T3-L1 adipogenic differentiation assays
3T3-L1 mouse embryonic ﬁbroblasts (preadipocytes) were maintained
in high-glucose (4.5 g/L) Dulbecco’s modiﬁed Eagle’s medium (DMEM;
Gibco) with 10% bovine serum (Sigma) and penicillin/streptomycin for
expansion (maintenance medium). Thereafter, 3T3-L1 cells wereMOLECULAR METABOLISM 4 (2015) 93e105  2014 The Authors. Published by Elsevier GmbH. This is an open access article un
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glucose DMEM, supplemented with 10% fetal bovine serum and
penicillin/streptomycin (experimental medium, all from Gibco) in a
humidiﬁed incubator at 5% CO2. Two days post-conﬂuence, cells were
incubated in “induction medium”, containing 172 nM insulin, 1 mM
dexamethasone and 115 mg/mL isobutyl-methylxanthine (all from
Sigma) and 10% macrophage-conditioned media. After 2 days, the
medium was changed to insulin medium, which contained 10%
macrophage-conditioned media and 172 nM insulin, and this medium
was applied every two days. At day 10, cells were ﬁxed with 4% PFA
and stained with BODIPY 493/503, Syto60 and Hoechst (all from
Invitrogen) to acquire images of lipid droplets, cytosol and nuclei,
respectively. The percentage of differentiated adipocytes was analyzed
with CellProﬁler software as described [49].
4.11. Analysis of gene expression
RNA was extracted from isolated adipocytes or adipose tissue with the
RNeasy Mini Kit (Qiagen), and from polarized macrophages and iso-
lated adipose tissue macrophages using the RNeasy Plus Micro Kit
(Qiagen). cDNA was transcribed from 500 ng RNA template, using the
High Capacity Reverse Transcription kit (Applied Biosystems). The PCR
reactions were performed using FastStart SYBR green master mix
(Roche) and a 7900HT Fast Real-Time PCR System (Applied Bio-
systems). Rplp0 (36B4) was used as internal control and fold changes
of gene expression were calculated using the DDCT method. The
primer sequences are provided in Table S2.
4.12. Transwell migration assay
CD11bþ cells were isolated from the peritoneal lavages of 20-week-
old WT mice (n ¼ 3) by MACS (Miltenyi Biotech), and 2  104 cells
were seeded onto 24-well transwell inserts (pore size 8 mm, Corning).
The medium in the bottom chamber consisted of RPMI medium (Gibco)
supplemented with 1% FBS and either 200 ng/mL human VEGF-C
(kind gift from M. Jeltsch, University of Helsinki, Finland [51]),
200 ng/mL murine VEGF-D (R&D Systems) or 200 ng/mL BSA. For
receptor blocking studies, 10 mg/mL of rat anti-mouse VEGFR-2
antibody DC101, rat anti-mouse VEGFR-3 antibody mF4-31C1 (both
from Imclone Systems Inc.), sVEGFR-3eIg (R&D), control rat IgG
(SigmaeAldrich), mouse anti-mouse Nrp-1A, mouse anti-mouse Nrp-
1B, mouse anti-mouse Nrp-2B mAb or control mouse IgG (all from
Genentech) were added to the bottom chamber, either with or without
human VEGF-C (200 ng/mL). After 3 days, the cells on the top of the
membrane were removed, and the migrated cells on the bottom side
were ﬁxed and stained with Hoechst nuclear stain. Migrated cells were
counted manually and their migratory capacity was normalized against
the level of migration towards IgG þ VEGF-C or IgG þ VEGF-D.
4.13. Polarization of bone marrow derived macrophages
Bone marrow derived cells were harvested by ﬂushing the femurs and
tibiae of 24-week-old WT mice with sterile PBS. Monocytes (4  106)
were plated into 6-well plates and differentiated to macrophages by in-
cubation in RPMI medium supplemented with 1% FBS and 100 ng/mL M-
CSF (BioLegend) for six days. Cells werewashed extensively and polarized
towards eitherM1macrophageswith IFN-g, or towardsM2macrophages,
using a combination of M-CSF, IL-4, IL-13 and IL-10 (all from BioLegend;
20 ng/mL ﬁnal concentration). Controls were incubated in RPMI medium
with 1% FBS. Cell lysates were collected after 24 h for RNA isolation.
4.14. Statistics
Data are presented as mean  SD, and sample sizes and statistical
tests used are indicated in the ﬁgure legends. Weight-gain and insulinder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). 103
Original articletolerance test data were analyzed with two-way ANOVA for curve
comparison and two-tailed Student’s t-test for time-point compari-
sons. Adipocyte sizes were analyzed using the two-sample Kolmo-
goroveSmirnov test. Means of two groups were compared with the
two-tailed Student’s t-test. Means of three or more groups were
analyzed with one-way ANOVA with Tukey’s post-hoc test. Analyses
were performed using GraphPad Prism V6.0 for MacOSX (GraphPad
Software, San Diego California, USA), PASWStatistics 18.0 (SPSS Inc,
Chicago, IL) or Matlab version 7.12.0.635 R2011a (Mathworks, Inc.).
Statistical signiﬁcance was set at P < 0.05.
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